Highlights
Publications
12 publications
Funding
2 grants
Active
1 grant- Co-IBP 242175-01First-in-Class Dual AR-V7/AR-fl Molecular Glue Degrader for Prostate Cancer TreatmentDaedalus Fund for Innovation (Weill Cornell) · 2024–2027BioPharma Alliance
Completed grants (1)
- KPBP 214751-01Development of Selective Small Molecule AR-V7 Inhibitors for Prostate Cancer TreatmentDaedalus Fund for Innovation (Weill Cornell) · 2021–2023BioPharma Alliance
News mentions
1 mentionView all WCM news ↗
- Prostate Cancer Foundation Awards Grants to Weill Cornell Medicine InvestigatorsMarch 26, 2026
Six researchers from Weill Cornell Medicine have received Young Investigator Awards from the Prostate Cancer Foundation.
External relationships
Ownership
Arma Bio, Inc.
Professional Services
Arma Bio, Inc.